Browse > Article
http://dx.doi.org/10.1055/s-0042-1748664

Misdiagnosis of Human Herpes Virus-8-Associated Kaposi's Sarcoma as Adverse Drug Eruptions  

Kim, Tae Hyung (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine)
Wee, Syeo Young (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine)
Jeong, Hyun Gyo (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine)
Choi, Hwan Jun (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.49, no.3, 2022 , pp. 457-461 More about this Journal
Abstract
Kaposi's sarcoma (KS) is a cancer that causes patches of abnormal tissue to grow under the skin. It also occurs in the immunosuppressive population. KS is currently believed to be caused by infection with human herpes virus-8 (HHV-8) in non-human immunodeficiency virus patient. A 79-year-old female visited the outpatient clinic presenting with increasing number and size of palpable masses on both upper and lower extremities. She was first diagnosed as drug-erupted dermatitis and stopped her medications, but the symptoms got worse. We did partial biopsy, and KS with HHV-8 was diagnosed histopathologically. She planned to undergo further evaluations and proper treatments. This rare case suggests the need to consider a classic type of KS in the differential diagnosis of specific dermatologic symptoms such as macular, nodular, and darkish patches of upper or lower extremities in elderly patients. It is believed that this case helps to strengthen awareness of this rare disease.
Keywords
extremities; non-AIDS-related Kaposi sarcoma; adverse drug reactions;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Reid E, Suneja G, Ambinder RF, et al; CGC. AIDS-related Kaposi sarcoma, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(02):171-189   DOI
2 Tsao MN, Sinclair E, Assaad D, et al. Radiation therapy for the treatment of skin Kaposi sarcoma. Ann Palliat Med 2016;5(04):298-302   DOI
3 Lebbe C, Garbe C, Stratigos AJ, et al;European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC) Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer 2019;114:117-127   DOI
4 Nickoloff BJ, Foreman KE. Etiology and pathogenesis of Kaposi's sarcoma. In: Dummer R, Nestle FO, Burg G., eds. Cancers of the Skin. vol. 160, Berlin, Heidelberg:: Springer;; 2002:331-342
5 Schwartz RA. Kaposi's sarcoma: an update. J Surg Oncol 2004;87(03):146-151   DOI
6 Rescigno P, Di Trolio R, Buonerba C, et al. Non-AIDS-related Kaposi's sarcoma: a single-institution experience. World J Clin Oncol 2013;4(02):52-57   DOI
7 Oyucu Orhan S, Bilgehan Sahin A, Cubukcu E, et al. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: a single-center retrospective real-world data. Bosn J Basic Med Sci 2021;21(06):746-751
8 Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol 2017;18(04):529-539   DOI
9 Krown SE, Moser CB, MacPhail P, et al;A5263/AMC066 protocol team. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet 2020;395(10231):1195-1207   DOI
10 Kamiyango W, Villiera J, Silverstein A, Peckham-Gregory E, Campbell LR, El-Mallawany NK. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev 2019;38(04):749-758   DOI
11 Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol 2008;53(01):2-8   DOI
12 Vangipuram R, Tyring SK. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int J Dermatol 2019;58(05):538-542   DOI
13 Lanternier F, Lebbe C, Schartz N, et al. Kaposi's sarcoma in HIV-negative men having sex with men. AIDS 2008;22(10):1163-1168   DOI
14 Krown SE, Lee JY, Lin L, et al. Interferon-a2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma. J Acquir Immune Defic Syndr 2006;41:5
15 Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28(03):371-395   DOI